Byker, H. P., Soltani, N., Robinson, D. E., Tardif, F. J., Lawton, M. B. and Sikkema, P. H. 2013. Glyphosate-resistant Canada fleabane [Conyza canadensis(L). Cronq.]: Dose response to glyphosate and control with postemergence herbicides in soybean in Ontario. Can. J. Plant Sci. 93: 1187-1193. Glyphosate-resistant (GR) Canada fleabane was first reported in Ontario in 2010. Twelve field studies were conducted over a 2-yr period (2011, 2012) to determine the biologically effective dose of glyphosate in the field and to determine the efficacy of postemergence herbicides for control of GR Canada fleabane. A dose between 1271 and 5652 g a.e. ha-1 was required for a 50% reduction in Canada fleabane biomass depending on site and year. To achieve acceptable (>95%) control with glyphosate, 18 840 to 43 200 g a.e. ha-1 of glyphosate was required across all sites. Therefore application of glyphosate at these doses for acceptable (>95%) control is not economical. None of the postemergence herbicides labeled for use in soybean provided acceptable (>95%) control, with cloransulam providing the greatest control (67%) 4 wk after application. Therefore, GR Canada fleabane must be controlled prior to soybean emergence as current herbicides registered in soybean for postemergence use do not provide sufficient control to prevent soybean yield loss.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.